KBFS
CANF

Kohmann Bosshard Financial Services’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Kohmann Bosshard Financial Services’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-170
Closed -$5.53K – 356
2024
Q4 		$5.53K Buy
+170
New +$6.9K ﹤0.01% 535

Other funds holding CANF

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CAM
Costello Asset Management Feasterville, Pennsylvania $289M AUM 27.04% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Kohmann Bosshard Financial Services's CANF Position: Q1 2025 in Review

Kohmann Bosshard Financial Services sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q1 2025, closing a stake of 170 shares — an estimated $5.53K sold.

Kohmann Bosshard Financial Services first reported a position in CANF in Q4 2024 and held it in 1 quarter. The position peaked at $5.53K in Q4 2024. 13 funds tracked by Wall St. Rank hold CANF as of Q1 2025.

  • Kohmann Bosshard Financial Services reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q1 2025 after selling out during the quarter.
  • Kohmann Bosshard Financial Services sold 170 Can-Fite BioPharma American Depositary Shares shares in Q1 2025, an estimated $5.53K.
  • Kohmann Bosshard Financial Services first reported a position in Can-Fite BioPharma American Depositary Shares in Q4 2024 and held it in 1 quarter.
  • Kohmann Bosshard Financial Services's Can-Fite BioPharma American Depositary Shares position peaked at $5.53K in Q4 2024.
  • 13 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q1 2025.

Based on Kohmann Bosshard Financial Services's 13F filing for Q1 2025, filed 12 May 2025.